According to the research report titled ‘GLOBAL METAGENOMICS MARKET 2019-2027‘, available with Market Study Report, global metagenomics market is anticipated to witness a yearly growth rate of 15.61% through 2027.
 

As per the report findings, rising awareness and developments pertaining to DNA sequencing devices and various platforms are the major factors driving the global metagenomics market growth. Furthermore, rising applications of metagenomics coupled with increasing collaboration among computing technologies and metagenomics experiments are enhancing the market outlook.  
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2515924/
 

Moreover, favorable government norms in emerging economies along with advancements in next-gen sequencing processes are poised to create opportunities for growth in the upcoming years. However, complications related to DNA sequencing processes or techniques and bioinformatics constraints are expected to limit global metagenomics market size over forecast period.
 

Based on regional overview, global metagenomics industry is segmented into Latin America, North America, Middle East and Africa, Asia-Pacific, and Europe. Among them, Asia-Pacific market is estimated to record a strong growth rate over the projected timeline owing to rising prevalence of cancer, surging cases of target diseases, and increasing healthcare expenditure in the region. Furthermore, high investments & funds and other emerging applications are slated to accelerate the regional industry expansion
 

China currently holds a significant share in Asia Pacific metagenomics market and is expected to showcase strong growth trends over the forecast duration, mainly due to rising middle-class population, fast aging population, and increasing burden of cancer in the region. Besides, high healthcare expenditure is also contributing to the market growth.  
 

Key players operating in worldwide metagenomics market are Qiagen N.V., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Integragen SA, GenoScreen, Oxford Nanopore Technologies, Ltd., Takara Bio, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Enterome SA, Swift Biosciences Inc., Illumina Inc., Pacific Biosciences Of California, Inc., PerkinElmer, Inc., and Bio-Rad Laboratories Inc.